Cite
HARVARD Citation
Yendamuri, S. et al. (2018). Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. European journal of cardio-thoracic surgery. pp. 656-663. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yendamuri, S. et al. (2018). Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. European journal of cardio-thoracic surgery. pp. 656-663. [Online].